From QAAPAPLE 1 to QAAPAPLE 2: how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs). (1st December 2020)
- Record Type:
- Journal Article
- Title:
- From QAAPAPLE 1 to QAAPAPLE 2: how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs). (1st December 2020)
- Main Title:
- From QAAPAPLE 1 to QAAPAPLE 2: how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs)
- Authors:
- Stip, Emmanuel
Grignon, Sylvain
Roy, Marc André
Bloom, David
Osman, Ossama
Amiri, Leena
Abdel Aziz, Karim
Javaid, Syed Fahad
Arnone, Danilo - Abstract:
- ABSTRACT: Background: In 2011, the authors published an algorithm summarizing practice guidelines related to the use of long-acting antipsychotics (LAIs) called the Québec Algorithme Antipsychotique à Action Prolongée (QAAPAPLE), and proposed that it be revised every 5–10 years to update it according to most recent scientific knowledge. Therefore, a re-evaluation of the algorithm was conducted to determine which recommendations were still relevant and which needed modification. Methods: The authors conducted a two-fold approach: a review of the literature to include new evidence since 2011 (controlled trials, meta-analyses, and practice guidelines); and a participatory component involving electronic surveys, conferences, encounters with opinion leadres, and patients' representatives. Results: Overall, prescribers tended to make decisions based on personal experience and conversations with colleagues rather than consulting evidence-based guidelines. To test if the algorithm was useful worldwide, it was presented in the United Arab Emirates, where the feedback was in agreement with the algorithm and its limitations. Conclusions: Since its initial publication, the QAAPAPLE algorithm has been updated to guide clinicians on the use of LAIs. The new algorithm has also been assessed outside Canada to test its generalizability worldwide, and indicated its flexibility, efficiency, and user-friendliness in order to guide clinicians on the use of LAIs.
- Is Part Of:
- Expert review of neurotherapeutics. Volume 20:Number 12(2020)
- Journal:
- Expert review of neurotherapeutics
- Issue:
- Volume 20:Number 12(2020)
- Issue Display:
- Volume 20, Issue 12 (2020)
- Year:
- 2020
- Volume:
- 20
- Issue:
- 12
- Issue Sort Value:
- 2020-0020-0012-0000
- Page Start:
- 1325
- Page End:
- 1332
- Publication Date:
- 2020-12-01
- Subjects:
- Antipsychotics -- long-acting injections -- psychosis -- algorithm -- QAAPAPLE
Neuropharmacology -- Periodicals
615.7805 - Journal URLs:
- http://www.expert-reviews.com/loi/ern ↗
http://www.future-drugs.com/loi/ern ↗
http://www.tandfonline.com/toc/iern20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14737175.2020.1826930 ↗
- Languages:
- English
- ISSNs:
- 1473-7175
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002995
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 22663.xml